LGLQX | RGAHX | LGLQX / RGAHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 9 years | - |
Gain YTD | 43.991 | 29.960 | 147% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.16B | 306B | 2% |
Annual Yield % from dividends | 0.00 | 0.64 | - |
Returns for 1 year | 51.37 | 31.44 | 163% |
Returns for 3 years | -14.40 | -1.17 | 1,228% |
Returns for 5 years | 55.22 | 57.44 | 96% |
Returns for 10 years | 93.53 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHEIX | 12.93 | N/A | N/A |
T. Rowe Price Hedged Equity I | |||
RIDAX | 25.66 | -0.04 | -0.16% |
American Funds Income Fund of Amer R1 | |||
ARTQX | 16.98 | -0.05 | -0.29% |
Artisan Mid Cap Value Investor | |||
PWEAX | 13.39 | -0.09 | -0.67% |
PACE International Em Mkts Eq A | |||
BIPIX | 69.20 | -0.52 | -0.75% |
ProFunds Biotechnology UltraSector Inv |